HIGHLIGHTS
- who: Zahid Rafiq Bhat and collaborators from the Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sahibzada Ajit Nagar, India School of Health Sciences, Central University of Punjab, Bathinda, India have published the Article: In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor inNude Mice, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: The authors further explored the 6b compound in vivo by employing the A549-induced xenograft model in
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.